| Form N-CSR Cover | 12 Months Ended |
| Oct. 31, 2024 | |
| Shareholder Report [Line Items] | |
| Document Type | N-CSR |
| Amendment Flag | false |
| Registrant Name | T. ROWE PRICE INTERNATIONAL FUNDS, INC. |
| Entity Central Index Key | 0000313212 |
| Entity Investment Company Type | N-1A |
| Document Period End Date | Oct. 31, 2024 |
| Shareholder Report | 12 Months Ended | 44 Months Ended | 92 Months Ended |
| Oct. 31, 2024 USD ($) Holding | Oct. 31, 2024 USD ($) Holding | Oct. 31, 2024 USD ($) Holding | |
| Shareholder Report [Line Items] | |||
| Document Type | N-CSR | ||
| Amendment Flag | false | ||
| Registrant Name | T. ROWE PRICE INTERNATIONAL FUNDS, INC. | ||
| Entity Central Index Key | 0000313212 | ||
| Entity Investment Company Type | N-1A | ||
| Document Period End Date | Oct. 31, 2024 | ||
| C000004011 | |||
| Shareholder Report [Line Items] | |||
| Fund Name | European Stock Fund | ||
| Class Name | Investor Class | ||
| Trading Symbol | PRESX | ||
| Shareholder Report Annual or Semi-Annual | Annual Shareholder Report | ||
| Additional Information [Text Block] | You can find the fund’s prospectus, financial information on Form N‑CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information at www.troweprice.com/prospectus info troweprice.com | ||
| Material Fund Change Notice [Text Block] | |||
| Additional Information Phone Number | 1‑800‑638‑5660 | ||
| Additional Information Email | info@troweprice.com</span>" id="sjs-B19"><span style="box-sizing: border-box; color: rgb(0, 0, 0); display: inline; flex-wrap: nowrap; font-size: 13.3333px; font-weight: 400; grid-area: auto; line-height: 17.3333px; margin: 0px; overflow: visible; text-align: justify;">info@troweprice.com</span> | ||
| Additional Information Website | www.troweprice.com/prospectus | ||
| Expenses [Text Block] | What were the fund costs for the last year? Costs of a $10,000 investment Costs paid as a percentage of a $10,000 investment European Stock Fund - Investor Class $116 1.04% | ||
| Expenses Paid, Amount | $ 116 | ||
| Expense Ratio, Percent | 1.04% | ||
| Factors Affecting Performance [Text Block] | What drove fund performance during the past 12 months? European shares rallied over the year as the European Central Bank began to cut interest rates in June. However, optimism was tempered by concerns over sluggish growth, disinflation, and political uncertainties. Within the portfolio, consumer staples and utilities, typically defensive sectors, were the main supporters of relative performance versus the MSCI Europe Index Net. Consumer staples contributed most due to positive stock picking and an underweight allocation. Unilever delivered the largest relative return as the company’s turnaround plan fueled strong margin expansion. Stock choices in utilities also helped. Our investment in Iberdrola benefited from falling interest rates, currency devaluations in Latin America, and higher tariffs in the U.S., which drove consensus-beating profit and revenue growth. Conversely, the leading detractor was the materials sector due to stock selection driven by Svenska Cellulosa and Akzo Nobel. The former fell as soft consumption in both Europe and China held back an expected recovery. The latter declined in challenging market conditions for paints that put pressure on profitability, leading the company to scrap its 2023 strategic targets and embark on a significant business transformation. An underweight allocation to industrials and business services was also negative. The fund is actively managed and seeks to provide long-term capital growth by investing primarily in companies located (or with primary operations) in Europe with quality management, strength of franchise, reasonable valuations, and strong cash flows. Notable changes to positioning included a larger allocation to health care and a smaller exposure to industrials and business services. | ||
| Performance Past Does Not Indicate Future [Text] | The fund’s past performance is not a good predictor of the fund’s future performance. | ||
| Average Annual Return [Table Text Block] | Average Annual Total Returns 1 Year 5 Years 10 Years European Stock Fund (Investor Class) 22.16 % 6.03 % 4.85 % MSCI Europe Index Net (Regulatory/Strategy Benchmark) 22.43 6.91 5.23 The preceding line graph shows the value of a hypothetical $10,000 investment in the fund over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The fund’s performance information included in the line graph and table above is compared with a regulatory required index that represents an overall securities market (Regulatory Benchmark). In addition, the line graph and table may also include one or more indexes that more closely aligns to the fund's investment strategy (Strategy Benchmark(s)). Due to new SEC Rules on shareholder reporting the fund adopted a new broad-based securities market index, referred to as the Regulatory Benchmark. Market index returns do not include expenses, which are deducted from fund returns. The fund's total return figures reflect the reinvestment of dividends and capital gains, if any.Neither the fund’s returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares. The fund’s past performance is not a good predictor of the fund’s future performance. | ||
| No Deduction of Taxes [Text Block] | Neither the fund’s returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares. | ||
| Performance Table Market Index Changed [Text Block] | Due to new SEC Rules on shareholder reporting the fund adopted a new broad-based securities market index, referred to as the Regulatory Benchmark. | ||
| Updated Performance Information Location [Text Block] | Updated performance information can be found at www.troweprice.com. | ||
| Distribution of Capital [Text Block] | The fund's total return figures reflect the reinvestment of dividends and capital gains, if any. | ||
| AssetsNet | $ 899,631,000 | $ 899,631,000 | $ 899,631,000 |
| Holdings Count | Holding | 65 | 65 | 65 |
| Advisory Fees Paid, Amount | $ 5,486,000 | ||
| InvestmentCompanyPortfolioTurnover | 25.90% | ||
| Additional Fund Statistics [Text Block] | What are some fund statistics? Fund Statistics Total Net Assets (000s) $899,631 Number of Portfolio Holdings 65 | ||
| Holdings [Text Block] | Sector Financials 22.6 % Health Care 17.6 Industrials & Business Services 10.5 Consumer Discretionary 8.9 Information Technology 8.9 Consumer Staples 7.7 Energy 6.1 Communication Services 5.9 Utilities 4.2 Other 7.6 | ||
| Largest Holdings [Text Block] | Top Ten Holdings Novo Nordisk 5.0 % ASML Holding 3.7 SAP 3.6 AstraZeneca 3.3 Unilever 2.9 TotalEnergies 2.7 Siemens 2.5 Allianz 2.5 LVMH Moet Hennessy Louis Vuitton 2.4 Iberdrola 2.4 | ||
| Material Fund Change [Text Block] | |||
| Updated Prospectus Web Address | www.troweprice.com/paperless | ||
| C000184317 | |||
| Shareholder Report [Line Items] | |||
| Fund Name | European Stock Fund | ||
| Class Name | I Class | ||
| Trading Symbol | TEUIX | ||
| Shareholder Report Annual or Semi-Annual | Annual Shareholder Report | ||
| Additional Information [Text Block] | You can find the fund’s prospectus, financial information on Form N‑CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information at www.troweprice.com/prospectus info troweprice.com | ||
| Material Fund Change Notice [Text Block] | |||
| Additional Information Phone Number | 1‑800‑638‑5660 | ||
| Additional Information Email | info@troweprice.com</span>" id="sjs-B49"><span style="box-sizing: border-box; color: rgb(0, 0, 0); display: inline; flex-wrap: nowrap; font-size: 13.3333px; font-weight: 400; grid-area: auto; line-height: 17.3333px; margin: 0px; overflow: visible; text-align: justify;">info@troweprice.com</span> | ||
| Additional Information Website | www.troweprice.com/prospectus | ||
| Expenses [Text Block] | What were the fund costs for the last year? Costs of a $10,000 investment Costs paid as a percentage of a $10,000 investment European Stock Fund - I Class $93 0.84% | ||
| Expenses Paid, Amount | $ 93 | ||
| Expense Ratio, Percent | 0.84% | ||
| Factors Affecting Performance [Text Block] | What drove fund performance during the past 12 months? European shares rallied over the year as the European Central Bank began to cut interest rates in June. However, optimism was tempered by concerns over sluggish growth, disinflation, and political uncertainties. Within the portfolio, consumer staples and utilities, typically defensive sectors, were the main supporters of relative performance versus the MSCI Europe Index Net. Consumer staples contributed most due to positive stock picking and an underweight allocation. Unilever delivered the largest relative return as the company’s turnaround plan fueled strong margin expansion. Stock choices in utilities also helped. Our investment in Iberdrola benefited from falling interest rates, currency devaluations in Latin America, and higher tariffs in the U.S., which drove consensus-beating profit and revenue growth. Conversely, the leading detractor was the materials sector due to stock selection driven by Svenska Cellulosa and Akzo Nobel. The former fell as soft consumption in both Europe and China held back an expected recovery. The latter declined in challenging market conditions for paints that put pressure on profitability, leading the company to scrap its 2023 strategic targets and embark on a significant business transformation. An underweight allocation to industrials and business services was also negative. The fund is actively managed and seeks to provide long-term capital growth by investing primarily in companies located (or with primary operations) in Europe with quality management, strength of franchise, reasonable valuations, and strong cash flows. Notable changes to positioning included a larger allocation to health care and a smaller exposure to industrials and business services. | ||
| Performance Past Does Not Indicate Future [Text] | The fund’s past performance is not a good predictor of the fund’s future performance. | ||
| Average Annual Return [Table Text Block] | Average Annual Total Returns 1 Year 5 Years Since Inception 3/6/17 European Stock Fund (I Class) 22.37 % 6.21 % 7.24 % MSCI Europe Index Net (Regulatory/Strategy Benchmark) 22.43 6.91 7.05 The preceding line graph shows the value of a hypothetical $500,000 investment in the fund over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The fund’s performance information included in the line graph and table above is compared with a regulatory required index that represents an overall securities market (Regulatory Benchmark). In addition, the line graph and table may also include one or more indexes that more closely aligns to the fund's investment strategy (Strategy Benchmark(s)). Due to new SEC Rules on shareholder reporting the fund adopted a new broad-based securities market index, referred to as the Regulatory Benchmark. Market index returns do not include expenses, which are deducted from fund returns. The fund's total return figures reflect the reinvestment of dividends and capital gains, if any.Neither the fund’s returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares. The fund’s past performance is not a good predictor of the fund’s future performance. | ||
| Performance Inception Date | Mar. 06, 2017 | ||
| No Deduction of Taxes [Text Block] | Neither the fund’s returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares. | ||
| Performance Table Market Index Changed [Text Block] | Due to new SEC Rules on shareholder reporting the fund adopted a new broad-based securities market index, referred to as the Regulatory Benchmark. | ||
| Updated Performance Information Location [Text Block] | Updated performance information can be found at www.troweprice.com. | ||
| Distribution of Capital [Text Block] | The fund's total return figures reflect the reinvestment of dividends and capital gains, if any. | ||
| AssetsNet | $ 899,631,000 | $ 899,631,000 | $ 899,631,000 |
| Holdings Count | Holding | 65 | 65 | 65 |
| Advisory Fees Paid, Amount | $ 5,486,000 | ||
| InvestmentCompanyPortfolioTurnover | 25.90% | ||
| Additional Fund Statistics [Text Block] | What are some fund statistics? Fund Statistics Total Net Assets (000s) $899,631 Number of Portfolio Holdings 65 | ||
| Holdings [Text Block] | Sector Financials 22.6 % Health Care 17.6 Industrials & Business Services 10.5 Consumer Discretionary 8.9 Information Technology 8.9 Consumer Staples 7.7 Energy 6.1 Communication Services 5.9 Utilities 4.2 Other 7.6 | ||
| Largest Holdings [Text Block] | Top Ten Holdings Novo Nordisk 5.0 % ASML Holding 3.7 SAP 3.6 AstraZeneca 3.3 Unilever 2.9 TotalEnergies 2.7 Siemens 2.5 Allianz 2.5 LVMH Moet Hennessy Louis Vuitton 2.4 Iberdrola 2.4 | ||
| Material Fund Change [Text Block] | |||
| Updated Prospectus Web Address | www.troweprice.com/paperless | ||
| C000225808 | |||
| Shareholder Report [Line Items] | |||
| Fund Name | European Stock Fund | ||
| Class Name | Z Class | ||
| Trading Symbol | TRZPX | ||
| Shareholder Report Annual or Semi-Annual | Annual Shareholder Report | ||
| Additional Information [Text Block] | You can find the fund’s prospectus, financial information on Form N‑CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information at www.troweprice.com/prospectus info troweprice.com | ||
| Material Fund Change Notice [Text Block] | |||
| Additional Information Phone Number | 1‑800‑638‑5660 | ||
| Additional Information Email | info@troweprice.com</span>" id="sjs-B80"><span style="box-sizing: border-box; color: rgb(0, 0, 0); display: inline; flex-wrap: nowrap; font-size: 13.3333px; font-weight: 400; grid-area: auto; line-height: 17.3333px; margin: 0px; overflow: visible; text-align: justify;">info@troweprice.com</span> | ||
| Additional Information Website | www.troweprice.com/prospectus | ||
| Expenses [Text Block] | What were the fund costs for the last year? Costs of a $10,000 investment Costs paid as a percentage of a $10,000 investment European Stock Fund - Z Class $0 0.00% | ||
| Expenses Paid, Amount | $ 0 | ||
| Expense Ratio, Percent | 0% | ||
| Factors Affecting Performance [Text Block] | What drove fund performance during the past 12 months? European shares rallied over the year as the European Central Bank began to cut interest rates in June. However, optimism was tempered by concerns over sluggish growth, disinflation, and political uncertainties. Within the portfolio, consumer staples and utilities, typically defensive sectors, were the main supporters of relative performance versus the MSCI Europe Index Net. Consumer staples contributed most due to positive stock picking and an underweight allocation. Unilever delivered the largest relative return as the company’s turnaround plan fueled strong margin expansion. Stock choices in utilities also helped. Our investment in Iberdrola benefited from falling interest rates, currency devaluations in Latin America, and higher tariffs in the U.S., which drove consensus-beating profit and revenue growth. Conversely, the leading detractor was the materials sector due to stock selection driven by Svenska Cellulosa and Akzo Nobel. The former fell as soft consumption in both Europe and China held back an expected recovery. The latter declined in challenging market conditions for paints that put pressure on profitability, leading the company to scrap its 2023 strategic targets and embark on a significant business transformation. An underweight allocation to industrials and business services was also negative. The fund is actively managed and seeks to provide long-term capital growth by investing primarily in companies located (or with primary operations) in Europe with quality management, strength of franchise, reasonable valuations, and strong cash flows. Notable changes to positioning included a larger allocation to health care and a smaller exposure to industrials and business services. | ||
| Performance Past Does Not Indicate Future [Text] | The fund’s past performance is not a good predictor of the fund’s future performance. | ||
| Average Annual Return [Table Text Block] | Average Annual Total Returns 1 Year Since Inception 2/22/21 European Stock Fund (Z Class) 23.42 % 3.82 % MSCI Europe Index Net (Regulatory/Strategy Benchmark) 22.43 5.57 The preceding line graph shows the value of a hypothetical $10,000 investment in the fund over the past 10 fiscal year periods or since inception (for funds lacking 10-year records). The fund’s performance information included in the line graph and table above is compared with a regulatory required index that represents an overall securities market (Regulatory Benchmark). In addition, the line graph and table may also include one or more indexes that more closely aligns to the fund's investment strategy (Strategy Benchmark(s)). Due to new SEC Rules on shareholder reporting the fund adopted a new broad-based securities market index, referred to as the Regulatory Benchmark. Market index returns do not include expenses, which are deducted from fund returns. The fund's total return figures reflect the reinvestment of dividends and capital gains, if any.Neither the fund’s returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares. The fund’s past performance is not a good predictor of the fund’s future performance. | ||
| Performance Inception Date | Feb. 22, 2021 | ||
| No Deduction of Taxes [Text Block] | Neither the fund’s returns nor the index returns reflect the deduction of taxes that a shareholder would pay on fund distributions or redemptions of fund shares. | ||
| Performance Table Market Index Changed [Text Block] | Due to new SEC Rules on shareholder reporting the fund adopted a new broad-based securities market index, referred to as the Regulatory Benchmark. | ||
| Updated Performance Information Location [Text Block] | Updated performance information can be found at www.troweprice.com. | ||
| Distribution of Capital [Text Block] | The fund's total return figures reflect the reinvestment of dividends and capital gains, if any. | ||
| AssetsNet | $ 899,631,000 | $ 899,631,000 | $ 899,631,000 |
| Holdings Count | Holding | 65 | 65 | 65 |
| Advisory Fees Paid, Amount | $ 5,486,000 | ||
| InvestmentCompanyPortfolioTurnover | 25.90% | ||
| Additional Fund Statistics [Text Block] | What are some fund statistics? Fund Statistics Total Net Assets (000s) $899,631 Number of Portfolio Holdings 65 | ||
| Holdings [Text Block] | Sector Financials 22.6 % Health Care 17.6 Industrials & Business Services 10.5 Consumer Discretionary 8.9 Information Technology 8.9 Consumer Staples 7.7 Energy 6.1 Communication Services 5.9 Utilities 4.2 Other 7.6 | ||
| Largest Holdings [Text Block] | Top Ten Holdings Novo Nordisk 5.0 % ASML Holding 3.7 SAP 3.6 AstraZeneca 3.3 Unilever 2.9 TotalEnergies 2.7 Siemens 2.5 Allianz 2.5 LVMH Moet Hennessy Louis Vuitton 2.4 Iberdrola 2.4 | ||
| Material Fund Change [Text Block] | |||
| Updated Prospectus Web Address | www.troweprice.com/paperless |
| Shareholder Report, Line Graph (Details) - MSCI Europe Index Net - USD ($) | Oct. 31, 2024 | Jul. 31, 2024 | Apr. 30, 2024 | Jan. 31, 2024 | Oct. 31, 2023 | Jul. 31, 2023 | Apr. 30, 2023 | Jan. 31, 2023 | Oct. 31, 2022 | Jul. 31, 2022 | Apr. 30, 2022 | Jan. 31, 2022 | Oct. 31, 2021 | Jul. 31, 2021 | Apr. 30, 2021 | Feb. 22, 2021 | Jan. 31, 2021 | Oct. 31, 2020 | Jul. 31, 2020 | Apr. 30, 2020 | Jan. 31, 2020 | Oct. 31, 2019 | Jul. 31, 2019 | Apr. 30, 2019 | Jan. 31, 2019 | Oct. 31, 2018 | Jul. 31, 2018 | Apr. 30, 2018 | Jan. 31, 2018 | Oct. 31, 2017 | Jul. 31, 2017 | Apr. 30, 2017 | Mar. 06, 2017 | Jan. 31, 2017 | Oct. 31, 2016 | Jul. 31, 2016 | Apr. 30, 2016 | Jan. 31, 2016 | Oct. 31, 2015 | Jul. 31, 2015 | Apr. 30, 2015 | Jan. 31, 2015 | Oct. 31, 2014 |
| Account Value [Line Items] | |||||||||||||||||||||||||||||||||||||||||||
| Account Value | $ 16,652 | $ 16,958 | $ 16,199 | $ 15,672 | $ 13,602 | $ 15,322 | $ 15,071 | $ 14,223 | $ 11,752 | $ 12,809 | $ 13,452 | $ 14,703 | $ 15,239 | $ 15,086 | $ 14,416 | $ 13,057 | $ 10,813 | $ 11,386 | $ 10,077 | $ 12,256 | $ 11,921 | $ 11,535 | $ 11,661 | $ 10,827 | $ 10,749 | $ 11,929 | $ 12,018 | $ 12,576 | $ 11,728 | $ 11,293 | $ 10,574 | $ 9,704 | $ 9,234 | $ 9,434 | $ 9,533 | $ 8,915 | $ 9,980 | $ 10,518 | $ 10,604 | $ 9,824 | $ 10,000 | ||
| Account Value | 842,069 | 857,543 | 819,136 | 792,524 | 687,818 | 774,802 | 762,104 | 719,230 | 594,283 | 647,708 | 680,246 | 743,502 | 770,631 | 762,889 | 728,987 | $ 660,261 | $ 546,813 | $ 575,780 | $ 509,599 | $ 619,765 | $ 602,844 | $ 583,291 | $ 589,680 | $ 547,484 | $ 543,581 | $ 603,253 | $ 607,710 | $ 635,928 | $ 593,055 | $ 571,092 | $ 534,731 | $ 500,000 | |||||||||||
| Account Value | $ 12,215 | $ 12,440 | $ 11,882 | $ 11,496 | $ 9,978 | $ 11,239 | $ 11,055 | $ 10,433 | $ 8,621 | $ 9,396 | $ 9,868 | $ 10,785 | $ 11,179 | $ 11,067 | $ 10,575 | $ 10,000 |
| Shareholder Report, Average Annual Return (Details) | 12 Months Ended | 44 Months Ended | 60 Months Ended | 92 Months Ended | 120 Months Ended |
| Oct. 31, 2024 | Oct. 31, 2024 | Oct. 31, 2024 | Oct. 31, 2024 | Oct. 31, 2024 | |
| Without Sales Load [Member] | C000004011 | |||||
| Average Annual Return [Line Items] | |||||
| Average Annual Return, Percent | 22.16% | 6.03% | 4.85% | ||
| Without Sales Load [Member] | C000184317 | |||||
| Average Annual Return [Line Items] | |||||
| Average Annual Return, Percent | 22.37% | 6.21% | 7.24% | ||
| Without Sales Load [Member] | C000225808 | |||||
| Average Annual Return [Line Items] | |||||
| Average Annual Return, Percent | 23.42% | 3.82% | |||
| MSCI Europe Index Net | |||||
| Average Annual Return [Line Items] | |||||
| Average Annual Return, Percent | 22.43% | 6.91% | 5.23% | ||
| MSCI Europe Index Net | |||||
| Average Annual Return [Line Items] | |||||
| Average Annual Return, Percent | 22.43% | 6.91% | 7.05% | ||
| MSCI Europe Index Net | |||||
| Average Annual Return [Line Items] | |||||
| Average Annual Return, Percent | 22.43% | 5.57% |
| Shareholder Report, Holdings (Details) | Oct. 31, 2024 |
| C000004011 | Novo Nordisk | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 5% |
| C000004011 | ASML Holding | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 3.70% |
| C000004011 | SAP | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 3.60% |
| C000004011 | AstraZeneca | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 3.30% |
| C000004011 | Unilever | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.90% |
| C000004011 | TotalEnergies | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.70% |
| C000004011 | Siemens | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.50% |
| C000004011 | Allianz | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.50% |
| C000004011 | LVMH Moet Hennessy Louis Vuitton | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.40% |
| C000004011 | Iberdrola | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.40% |
| C000004011 | Financials | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 22.60% |
| C000004011 | Health Care | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 17.60% |
| C000004011 | Industrials & Business Services | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 10.50% |
| C000004011 | Consumer Discretionary | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 8.90% |
| C000004011 | Information Technology | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 8.90% |
| C000004011 | Consumer Staples | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 7.70% |
| C000004011 | Energy | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 6.10% |
| C000004011 | Communication Services | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 5.90% |
| C000004011 | Utilities | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 4.20% |
| C000004011 | Other Holdings Grouping | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 7.60% |
| C000184317 | Novo Nordisk | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 5% |
| C000184317 | ASML Holding | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 3.70% |
| C000184317 | SAP | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 3.60% |
| C000184317 | AstraZeneca | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 3.30% |
| C000184317 | Unilever | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.90% |
| C000184317 | TotalEnergies | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.70% |
| C000184317 | Siemens | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.50% |
| C000184317 | Allianz | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.50% |
| C000184317 | LVMH Moet Hennessy Louis Vuitton | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.40% |
| C000184317 | Iberdrola | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.40% |
| C000184317 | Financials | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 22.60% |
| C000184317 | Health Care | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 17.60% |
| C000184317 | Industrials & Business Services | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 10.50% |
| C000184317 | Consumer Discretionary | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 8.90% |
| C000184317 | Information Technology | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 8.90% |
| C000184317 | Consumer Staples | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 7.70% |
| C000184317 | Energy | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 6.10% |
| C000184317 | Communication Services | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 5.90% |
| C000184317 | Utilities | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 4.20% |
| C000184317 | Other Holdings Grouping | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 7.60% |
| C000225808 | Novo Nordisk | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 5% |
| C000225808 | ASML Holding | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 3.70% |
| C000225808 | SAP | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 3.60% |
| C000225808 | AstraZeneca | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 3.30% |
| C000225808 | Unilever | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.90% |
| C000225808 | TotalEnergies | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.70% |
| C000225808 | Siemens | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.50% |
| C000225808 | Allianz | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.50% |
| C000225808 | LVMH Moet Hennessy Louis Vuitton | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.40% |
| C000225808 | Iberdrola | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 2.40% |
| C000225808 | Financials | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 22.60% |
| C000225808 | Health Care | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 17.60% |
| C000225808 | Industrials & Business Services | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 10.50% |
| C000225808 | Consumer Discretionary | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 8.90% |
| C000225808 | Information Technology | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 8.90% |
| C000225808 | Consumer Staples | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 7.70% |
| C000225808 | Energy | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 6.10% |
| C000225808 | Communication Services | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 5.90% |
| C000225808 | Utilities | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 4.20% |
| C000225808 | Other Holdings Grouping | |
| Holdings [Line Items] | |
| Percent of Net Asset Value | 7.60% |
